Norwalk Hospital — Norwalk, Connecticut

Public research footprint of Norwalk Hospital, compiled from the ClinicalTrials.gov public registry.

144

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Stage II Breast Cancer · Endometrial Dedifferentiated Carcinoma · Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm · Recurrent Platinum-Resistant Fallopian Tube Carcinoma

Recently updated registry entries

NCT04739800 — Comparison of Standard of Care Treatment With a Triplet Combination of Targeted… (Active Not Recruiting)
NCT02839707 — Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in… (Active Not Recruiting)
NCT02954874 — Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Norwalk Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.